ELBL, Lubomír, Hana HRSTKOVÁ, Iva TOMÁŠKOVÁ and Jaroslav MICHÁLEK. Late anthracycline cardiotoxicity protection by dextrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up (Late anthracyclone cardiotoxicity protection by dextrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up). Support Care Cancer. Heidelberg, Germany: Springer-Verlag, 2006, vol. 14, No 2, p. 128-136. ISSN 0941-4355.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Late anthracycline cardiotoxicity protection by dextrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up
Name in Czech Prevence pozdní kardiotoxicity daxtrazoxanem (ICRF-187) u dětských pacientů
Authors ELBL, Lubomír, Hana HRSTKOVÁ, Iva TOMÁŠKOVÁ and Jaroslav MICHÁLEK.
Edition Support Care Cancer, Heidelberg, Germany, Springer-Verlag, 2006, 0941-4355.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30209 Paediatrics
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.905
Organization unit Faculty of Medicine
UT WoS 000234732800004
Keywords (in Czech) Dextrazoxan, kardiotoxicita, děti
Keywords in English Dextrazoxane; anthracycline; cardiotoxicity;
Tags anthracycline, cardiotoxicity, Dextrazoxane
Tags Reviewed
Changed by Changed by: Věra Langrová, učo 34112. Changed: 7/7/2009 09:16.
Abstract
The authors conducted a retrospective study to determine whwther dexthrazoxane (ICRF-187) would reduce late anthracycline -inducted cardiotexicity in patients treated in childhood for hematology malignance.
Abstract (in Czech)
Dextrazoxan rtedukuje riziko pozdní koinické a subklinické kardiotoxicity a nesnižuj eúčinek chemoterqpie a celkové přežití během mediánu sledování 7 let
PrintDisplayed: 6/9/2024 13:37